APA

Hoskins P., Swenerton K., Wong F., Manji M., McMurtrie E., Le N. & Pike J. (1995). Platinum plus cyclophosphamide plus radiotherapy is superior to platinum alone in 'high-risk' epithelial ovarian cancer (residual negative and either stage I or II, grade 3, or stage III, any grade). : International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Chicago

Hoskins P.J, Swenerton K.D, Wong F, Manji M.F, McMurtrie E.M, Le N and Pike J. 1995. Platinum plus cyclophosphamide plus radiotherapy is superior to platinum alone in 'high-risk' epithelial ovarian cancer (residual negative and either stage I or II, grade 3, or stage III, any grade). : International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Harvard

Hoskins P., Swenerton K., Wong F., Manji M., McMurtrie E., Le N. and Pike J. (1995). Platinum plus cyclophosphamide plus radiotherapy is superior to platinum alone in 'high-risk' epithelial ovarian cancer (residual negative and either stage I or II, grade 3, or stage III, any grade). : International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

MLA

Hoskins P.J, Swenerton K.D, Wong F, Manji M.F, McMurtrie E.M, Le N and Pike J. Platinum plus cyclophosphamide plus radiotherapy is superior to platinum alone in 'high-risk' epithelial ovarian cancer (residual negative and either stage I or II, grade 3, or stage III, any grade). : International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 1995.